Cargando…

Management of statin myopathy

Detalles Bibliográficos
Autores principales:	Finsterer, Josef, Frank, Marlies
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476849/ https://www.ncbi.nlm.nih.gov/pubmed/28466578 http://dx.doi.org/10.1002/jcsm.12207

Ejemplares similares

Potential causes of sudden cardiac death in nemaline myopathy
por: Finsterer, Josef, et al.
Publicado: (2015)

Myopathy or Myasthenia Positive for Antibodies Against MuSK, Lrp4, and Titin
por: Finsterer, Josef, et al.
Publicado: (2020)

Specification of the Myopathy Type may Influence the Management of Noncompaction
por: Finsterer, Josef, et al.
Publicado: (2016)

SARS-CoV-2-associated critical ill myopathy or pure toxic myopathy?
por: Finsterer, Josef, et al.
Publicado: (2020)

Anti-mitochondrial antibody–mediated myopathy with cardiac involvement
por: Finsterer, Josef
Publicado: (2023)

Acquired non-compaction in integrin-myopathy
por: Finsterer, Josef, et al.
Publicado: (2013)

Autosomal Recessive Mitochondrial Myopathy due to MICU-1 Variants
por: Finsterer, Josef
Publicado: (2023)

Anti-mitochondrial M2 Antibodies and Myopathy
por: Finsterer, Josef, et al.
Publicado: (2017)

Camptocormia due to myotinilopathy, Parkinson’s disease, or both?: Camptocormia and axial myopathy
por: Finsterer, Josef
Publicado: (2023)

Creatine, guanidinoacetate and homoarginine in statin-induced myopathy
por: Neu, Axel, et al.
Publicado: (2020)

Mitochondrial myopathy plus due to the variant m.586G > A in MT-TF
por: Finsterer, Josef
Publicado: (2019)

Exclude differentials before attributing post-COVID fatigue to myopathy
por: Finsterer, Josef, et al.
Publicado: (2021)

Myopathy, athletism, pregnancy, race, and chromosomal defects need to be considered in noncompaction
por: Finsterer, Josef, et al.
Publicado: (2018)

Does SARS-CoV-2 truly cause infectious myopathy?
por: Finsterer, Josef, et al.
Publicado: (2021)

SARS-CoV-2 may unravel metabolic myopathy mistaken for myasthenia
por: Finsterer, Josef, et al.
Publicado: (2021)

BAG3-related myofibrillar myopathy requiring heart transplantation for restrictive cardiomyopathy
por: Finsterer, Josef, et al.
Publicado: (2018)

Comment on “CPEO and Mitochondrial Myopathy in a Patient with DGUOK Compound Heterozygous Pathogenetic Variant and mtDNA Multiple Deletions”
por: Finsterer, Josef
Publicado: (2020)

Diabetes due to Mitochondrial Adipopathy
por: Finsterer, Josef, et al.
Publicado: (2017)

Response letter: Management of statin‐induced myopathies: Much demands and still (almost) empty hands!
por: Sahebkar, Amirhossein, et al.
Publicado: (2017)

Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS) due to a m.10158T>C ND3 Mutation with a Normal Muscle Biopsy
por: Finsterer, Josef, et al.
Publicado: (2017)

Statin-Induced Immune-Mediated Necrotizing Myopathy Does Not Always Present With Immediate or Severe Symptoms
por: Kang, Minsung, et al.
Publicado: (2022)

Cerebellar Nocardiosis and Myopathy from Long-Term Corticosteroids for Idiopathic Thrombocytopenia
por: Frank, Marlies, et al.
Publicado: (2010)

Myopathy should determine the anesthetic management in left ventricular hypertrabeculation/noncompaction
por: Finsterer, J, et al.
Publicado: (2014)

Anaesthetic management of a case of distal myopathy
por: Agrawal, Neelam, et al.
Publicado: (2014)

Fractal genetics and heterogeneous phenotypes of mitochondrial disease require appropriate logistics of managing network structures
por: Finsterer, Josef
Publicado: (2019)

Pharmacogenomic insights into treatment and management of statin-induced myopathy
por: Peters, Bas JM, et al.
Publicado: (2009)

Comment on “Proximal Myopathy due to m.5835G>A Mutation in Mitochondrial MT-TY Gene”
por: Finsterer, J., et al.
Publicado: (2019)

SARS-CoV-2 Vaccination Related, Pediatric Guillain-Barre Syndrome Requires the Same Management as in Adults
por: Finsterer, Josef
Publicado: (2023)

Management of manifesting FOXRED1 carriers is complex
por: Finsterer, Josef, et al.
Publicado: (2019)

Statin-induced Myopathy
por: Fitzgerald, Kara, et al.
Publicado: (2012)

Management of Leigh syndrome due to NDUFAF6 variants
por: Finsterer, Josef, et al.
Publicado: (2019)

Update Review about Metabolic Myopathies
por: Finsterer, Josef
Publicado: (2020)

Zidovudine-induced myopathy
por: Wiwanitkit, Viroj
Publicado: (2011)

Necrotizing autoimmune myopathy
por: Babu, Sachin Suresh, et al.
Publicado: (2016)

Comment on "Drug–Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data"
por: Kuss, Oliver, et al.
Publicado: (2023)

Statin-Induced Autoimmune Myopathy
por: Nemati, Maryam, et al.
Publicado: (2021)

Comments on: Isolated Nonocompaction Suggests Subclinical Myopathy
por: Finsterer, Josef
Publicado: (2019)

Should statins be considered for the management of mucormycosis in COVID-19?
por: Chatterjee, Subhankar, et al.
Publicado: (2021)

Is myopathy part of long-Covid?
por: Rodriguez, Belén, et al.
Publicado: (2021)

Some DNM2 mutations cause extremely severe congenital myopathy and phenocopy myotubular myopathy
por: Biancalana, Valérie, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_t4vc5qtsblijd46068oek7d0fd